BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are placing greater ...
2h
What executives should know about advanced cancer screening, whole-body MRIs and longevity testing
Advanced screenings and longevity assessments are gaining traction in preventive health. But the value is more nuanced, according to Mayo Clinic’s Dr. Liz Gilman. In this Q&A, she shares where these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results